Categories
Amsacrine Anticancer Drugs Oncology Pharmacology Physiotherapy

Amsacrine (Experimental Notes-4)

In this article we will discuss Amsacrine (Experimental Notes-4)

In this article, we will discuss Amsacrine (Experimental Notes-4). So, let’s get started.

A number of reports have described the metabolism of amsacrine in rats and mice.
In mouse bile, 5′- and 6′-glutathione conjugates were present in roughly equal amounts and accounted for 70% of the excreted biliary radiolabel after administration of radio-labelled amsacrine (Robertson et al., 1988). In rats, the principal biliary metabolite was
the 5′-glutathione conjugate, which accounted for 80% of the excreted radiolabel within the first 90 min and > 50% of the administered dose over 3 h (Shoemaker et al., 1982). The 6′-conjugate was also subsequently identified in rat bile (Robertson et al., 1993). In rat liver microsomes and human neutrophils, intermediate oxidation products have
been identified as N1′-methanesulfonyl-N4′-(9-acridinyl)-3′-methoxy-2′,5′-cyclohexadiene-1′,4′-diimine and 3′-methoxy-4′-(9-acridinylamino-2′,5′-cyclohexadien-1′-one (Shoemaker et al., 1984; Kettle et al., 1992).

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from PT Master Guide

Subscribe now to keep reading and get access to the full archive.

Continue reading